Dosage form
Tablets white with a yellowish tint to white with kremovatym color, with inclusions, with valium and chamfer.
Composition
1 tab.

chondroitin sulfate 250 mg

Auxiliary substances: calcium stearate, crospovidone, polyvinylpyrrolidone (povidone), cellulose microcrystalline, magnesium carbonate.
Pharmacological action
The drug, regulates the metabolism in the cartilage tissue. Having hondrostimulirutee, regenerating and anti-inflammatory effect.

Hondroksid® involved in the construction of the basic substance of cartilage and bone. Influences on exchange processes in hyaline and fibrous cartilage. Hinders the process of degeneration of cartilage and connective tissue, by inhibiting the enzymes that cause cartilage damage of the.

Hondroksid® stimulates the biosynthesis of proteoglycans, promotes regeneration of articular capsule and cartilage surfaces of the joints, increases the production of synovial fluid, reduces inflammation.

The potential to prevent the formation of fibrin clots in synovial and subchondral microcirculatory bed.

Hondroksid® slows the progression of osteoarthritis and degenerative disc disease, normalizes metabolism in hyaline tissue, stimulates regeneration processes in the articular cartilage. In applying the drug reduces pain and improves the mobility of affected joints, while the therapeutic effect remains for a long period of time after the end of therapy.


Testimony
— treatment and prevention of osteoarthritis, degenerative disc disease of the spine.
Contraindications
— pregnancy;

— lactation;

— hypersensitivity to the drug.

With caution should use the drug with tendency to bleeding or them.
Drug interactions
May increase the action of indirect anticoagulants, antiplatelet agents, fibrinolitikov, which requires more frequent monitoring of indicators of blood coagulation, while the use of the Symptoms.